Pain pharmacology in migraine: focus on CGRP and CGRP receptors

被引:24
作者
Benemei, S.
Nicoletti, P.
Capone, J. A.
Geppetti, P. [1 ]
机构
[1] Univ Florence, Dept Crit Care Med & Surg, Clin Pharmacol Unit, I-50121 Florence, Italy
[2] Azienda Univ Osped S Anna, Dept Neurosci, Headache Ctr, Ferrara, Italy
关键词
calcitonin gene-related peptide; neurogenic vasodilatation; migraine; receptor antagonist; meninges;
D O I
10.1007/s10072-007-0757-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Over the last 100 years, the discovery of new analgesics has been a complex and difficult task. However, remarkable progress in the identification of novel molecular targets relevant for pain medicines has been reported. Here we will focus on the neuropeptide calcitonin gene-related peptide (CGRP) and its receptors (CGRP-R) because of their role in migraine mechanism and migraine therapy. Recent preclinical and clinical data on the localisation, regulation and plasma levels of CGRP and on the function of CGRP-R will be summarised. The reviewed findings highlight the major function of CGRP in migraine and the use of CGRP-R antagonists as a novel approach for the treatment of migraine attack and, perhaps, as migraine prophylactic medicines.
引用
收藏
页码:S89 / S93
页数:5
相关论文
共 39 条
[31]   NEUROGENICALLY MEDIATED LEAKAGE OF PLASMA-PROTEIN OCCURS FROM BLOOD-VESSELS IN DURA-MATER BUT NOT BRAIN [J].
MARKOWITZ, S ;
SAITO, K ;
MOSKOWITZ, MA .
JOURNAL OF NEUROSCIENCE, 1987, 7 (12) :4129-4136
[32]   Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine [J].
Olesen, J ;
Diener, H ;
Husstedt, IW ;
Goadsby, PJ ;
Hall, D ;
Meier, U ;
Pollentier, S ;
Lesko, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) :1104-1110
[33]   Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat [J].
Petersen, KA ;
Birk, S ;
Doods, H ;
Edvinsson, L ;
Olesen, J .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (06) :697-704
[34]   Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders [J].
Sarchielli, P ;
Pini, LA ;
Zanchin, G ;
Alberti, A ;
Maggioni, F ;
Rossi, C ;
Floridi, A ;
Calabresi, P .
CEPHALALGIA, 2006, 26 (03) :257-265
[35]   Response properties of dural nociceptors in relation to headache [J].
Strassman, AM ;
Levy, D .
JOURNAL OF NEUROPHYSIOLOGY, 2006, 95 (03) :1298-1306
[36]   Pharmacological characterization of novel α-calcitonin gene-related peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors [J].
Taylor, Christopher K. ;
Smith, D. David ;
Hulce, Martin ;
Abel, Peter W. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (02) :749-757
[37]   Modelling the anti-migraine effects of BIBN4096BS-: A new calcitonin gene-related peptide receptor antagonist [J].
Troconiz, Inaki F. ;
Wolters, Jan-Markus ;
Tillmann, Christiane ;
Schaefer, Hans G. ;
Roth, Willy .
CLINICAL PHARMACOKINETICS, 2006, 45 (07) :715-728
[38]   No increase of calcitonin gene-related peptide in jugular blood during migraine [J].
Tvedskov, JF ;
Lipka, K ;
Ashina, M ;
Iversen, HK ;
Schifter, S ;
Olesen, J .
ANNALS OF NEUROLOGY, 2005, 58 (04) :561-568
[39]   Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion [J].
Zhang, Zhongming ;
Winborn, Christina S. ;
de Prado, Blanca Marquez ;
Russo, Andrew F. .
JOURNAL OF NEUROSCIENCE, 2007, 27 (10) :2693-2703